EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incomplete paralog compensation generates selective dependency on TRA2A in cancer

Amanda R Lee iD, Anna Tangiyan, Isha Singh iD, Peter S Choi iD

PLOS Genetics · 14.05.2025 · 21 (5) · e1011685

DOI: 10.1371/journal.pgen.1011685 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Genetics, online erschienen am 14.05.2025. Verfasst von Amanda R Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of A…. Hauptthemen laut MEDLINE: Neoplasms, Serine-Arginine Splicing Factors, RNA-Binding Proteins, RNA Splicing Factors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paralogs often exhibit functional redundancy, allowing them to effectively compensate for each other’s loss. However, this buffering mechanism is frequently disrupted in cancer, exposing unique paralog-specific vulnerabilities. Here, we identify a selective dependency on the splicing factor TRA2A . We find that TRA2A and its paralog TRA2B are synthetic lethal partners that function as widespread and largely redundant activators of both alternative and constitutive splicing. While loss of TRA2A alone is typically neutral due to compensation by TRA2B , we discover that a subset of cancer cell lines are highly TRA2A -dependent. Upon TRA2A depletion, these cell lines exhibit a lack of paralog buffering specifically on shared splicing targets, leading to defects in mitosis and cell death. Notably, TRA2B overexpression rescues both the aberrant splicing and lethality associated with TRA2A loss, indicating that paralog compensation is dosage-sensitive. Together, these findings reveal a complex dosage-dependent relationship between paralogous splicing factors, and highlight how dysfunctional paralog buffering can create a selective dependency in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsSerine-Arginine Splicing FactorsRNA-Binding ProteinsRNA Splicing FactorsHumansCell Line, TumorAlternative SplicingGene Expression Regulation, NeoplasticMitosisRNA SplicingNerve Tissue Proteins

Substanzen

TRA2B protein, humanSerine-Arginine Splicing FactorsRNA-Binding ProteinsRNA Splicing FactorsNerve Tissue Proteins

Autor:innen und Institutionen

  • Department of Pathology & Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
  • Cell and Molecular Biology Graduate Group, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
  • Division of Cancer Pathobiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.

ORCID-Profile: Amanda R Lee, Isha Singh, Peter S Choi

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Lee, A. R., Tangiyan, A., Singh, I., & Choi, P. S. (2025). Incomplete paralog compensation generates selective dependency on TRA2A in cancer. PLOS Genetics, 21(5), e1011685. https://doi.org/10.1371/journal.pgen.1011685

Vancouver

Lee AR, Tangiyan A, Singh I, Choi PS. Incomplete paralog compensation generates selective dependency on TRA2A in cancer. PLOS Genetics. 2025;21(5):e1011685. doi:10.1371/journal.pgen.1011685

BibTeX
@article{Lee2025,
  author = {Lee, Amanda R and Tangiyan, Anna and Singh, Isha and Choi, Peter S},
  title = {Incomplete paralog compensation generates selective dependency on TRA2A in cancer},
  journal = {PLOS Genetics},
  year = {2025},
  volume = {21},
  number = {5},
  pages = {e1011685},
  doi = {10.1371/journal.pgen.1011685}
}
Kostenlos starten →